webinar register page

Webinar banner
Decentralized Clinical Trials in the Real World
The clinical trials industry has experienced rapid change as a result of decentralization and digitalization, prompting more questions from sponsors and clinical research organizations about current remote study operations best practices.

In this webinar, Signant's clinical science and digital health technology experts will explore a range of topics related to clinical research technology solutions and scientific strategies including:

① Maintaining assessment consistency and accuracy
② Pitfalls to avoid when selecting a telemedicine platform
③ Participant and site perspectives

Learn more below about our featured panelists:
- Dawie Wessels, Chief Medical Officer, Signant Health
- Bill Byrom, PhD - VP Product Positioning & Intelligence, Signant Health
- Emil Hoeck - Senior Director Business Development, Signant Health
- Günther Martin - Senior Director, Business Development, Signant Health

Don't miss this opportunity to learn formulas for decentralized research success from industry experts experienced in thousands of remote and multinational studies. Register below, and share with your colleagues and social networks.
Webinar logo
* Required information


Dawie Wessels
Chief Medical Officer @Signant Health
As Chief Medical Officer of Signant Health, Dawie marries therapeutic-area expertise with business leadership in multinational commercial development and growth. With over twenty years' experience combining medicine and business, Dawie oversees Signant's scientific and operational strategies.
Bill Byrom, Ph.D.
VP Product Positioning & Intelligence @Signant Health
Bill serves as Vice President of product intelligence and positioning at Signant Health, where he also serves as a principal ePRO scientist. He has worked in the pharmaceutical industry for 30 years, authoring over 70 publications and two industry textbooks on electronic patient-reported outcomes (ePRO). His recent scientific work includes leading a cross-disciplinary group on the use of endpoints derived from wearable devices to support labelling claims and regulatory decision making.
Emil Hoeck
Senior Director @Signant Health
Emil Hoeck is a clinical research professional with wide-ranging experience. He began his career as study coordinator at a dedicated clinical research site and later transitioned into the CRO world with responsibilities ranging from client relations and quality assurance to site relationship strategy in a wide range of therapy areas including psychiatry, pediatrics, ophthalmology, oncology, and vaccines. Today, Hoeck serves as Senior Director of Business Development at Signant Health and represents company interests outside the United States.
Günther Martin
Senior Director, Business Development @Signant Health
Günther Martin is an experienced sales and business development professional with more than 20 years of experience working in top technology companies worldwide while helping his customers to improve their business processes by implementing new technologies and solutions. Günther worked over the last decade with many Life Sciences companies to dynamically address customer requirements and regulatory mandates to improve time to market, mitigate risk, ensure traceability, reduce supply chain complexity, optimize costs and increase agility.Today, Günther serves as Senior Senior Director of Business Development at Signant Health and represents company interests in the DACH & Easter Europe region.